as 12-11-2024 4:00pm EST
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
Founded: | 2014 | Country: | United States |
Employees: | N/A | City: | BOSTON |
Market Cap: | 206.3M | IPO Year: | N/A |
Target Price: | $7.67 | AVG Volume (30 days): | 510.2K |
Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.35 | EPS Growth: | N/A |
52 Week Low/High: | $0.77 - $2.34 | Next Earning Date: | 11-12-2024 |
Revenue: | $850,000 | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | 610.48% |
CMPX Breaking Stock News: Dive into CMPX Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
Simply Wall St.
8 days ago
GlobeNewswire
10 days ago
GlobeNewswire
a month ago
GlobeNewswire
a month ago
GlobeNewswire
a month ago
Simply Wall St.
a month ago
GlobeNewswire
2 months ago
The information presented on this page, "CMPX Compass Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.